U.S. markets closed

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
15.70+0.10 (+0.67%)
At close: 9:30AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/6/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
27.87B28.71B27.55B31.06B28.72B
Enterprise Value 3
24.88B25.85B25.23B28.02B26.11B
Trailing P/E
21.4420.9615.7817.6314.68
Forward P/E 1
12.0611.9214.0816.3412.71
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.382.322.322.652.52
Price/Book (mrq)
2.172.202.252.642.43
Enterprise Value/Revenue 3
0.020.080.080.090.08
Enterprise Value/EBITDA 7
0.100.280.540.351.05

Trading Information

Stock Price History

Beta (5Y Monthly) 0.61
52-Week Change 3-8.07%
S&P500 52-Week Change 344.45%
52 Week High 317.95
52 Week Low 313.50
50-Day Moving Average 315.12
200-Day Moving Average 315.42

Share Statistics

Avg Vol (3 month) 35.48k
Avg Vol (10 day) 3350
Shares Outstanding 51.86B
Implied Shares Outstanding 6N/A
Float 1.86B
% Held by Insiders 10.58%
% Held by Institutions 156.90%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.46
Forward Annual Dividend Yield 42.97%
Trailing Annual Dividend Rate 342.00
Trailing Annual Dividend Yield 3269.32%
5 Year Average Dividend Yield 42.28
Payout Ratio 454.88%
Dividend Date 3Jun 17, 2018
Ex-Dividend Date 4Sep 28, 2021
Last Split Factor 25:1
Last Split Date 3Mar 26, 2014

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 30, 2021
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 9.65%
Operating Margin (ttm)17.97%

Management Effectiveness

Return on Assets (ttm)6.11%
Return on Equity (ttm)9.02%

Income Statement

Revenue (ttm)1.25T
Revenue Per Share (ttm)672.83
Quarterly Revenue Growth (yoy)-1.20%
Gross Profit (ttm)1T
EBITDA 297.22B
Net Income Avi to Common (ttm)120.59B
Diluted EPS (ttm)0.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)331.69B
Total Cash Per Share (mrq)178.69
Total Debt (mrq)120B
Total Debt/Equity (mrq)8.66
Current Ratio (mrq)1.47
Book Value Per Share (mrq)746.73

Cash Flow Statement

Operating Cash Flow (ttm)306.84B
Levered Free Cash Flow (ttm)-193.46B